Состояние системы коагуляции у пациентов с центральным несахарным диабетом, получающих десмопрессин, и у пациентов с первичной полидипсией
https://doi.org/10.14341/2071-8713-5105
Список литературы
1. Balduini C.L., Noris P., Belletti S., Spedini P., Gamba G. In vitro and in vivo effects of desmopressin on platelet function. Haematologica 1999; 84:891-96.
2. Cash J.D., Garder A.M., Costa J.D. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-D-arginine vasopressin, angiotensin and oxytocin in man. Br J Haematol 1974; 27:363-4.
3. Goodfriend T.L., Friedman A.L., Shenker Y. Hormonal regulation of electrolyte and water metabolism. Endocrinology, 5th Edition. Edited by DeGroot LJ and Jameson JL. Chapter 133, 2006.
4. Green N.D., Blumberg J.B. The use of a synthetic analogue of posthypophysial vasopressin (PLV-2) for local haemostasis. Surgery. 1965 Sep;58:524-9.
5. Haemophilia and haemostasis; a case-based approach to management. Ed. by Harold Ross Roberts. Blackwell Publishing 2007; 229 p.
6. Holemans R. Origin of blood fibrinolytic activity. Lancet. 1963 Aug 17; 2(7303):364-5.
7. Kaumann J.E., Vischer U.M. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis. 2003 1:682-689.
8. Mannucci P.M., Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years Blood 1997; 90:2515-21.
9. Mannucci P.M., Gagnatelli G., d'Alonzo R., Thrombosis: risk factors and diagnostic approaches. Stress and Blood Coagulation (Brinkhous K.M., Hinnom S. ed.). Stuttgart: Schattauer Verlag 1972, 105-10.
10. Mannucci P.M., Pareti F.I., Holmberg L., Nilsson I.M., Ruggeri Z.M. Studies on the prolonged bleeding time in von Willebrand's disease. J Lab Clin Med. 1976 Oct;88(4):662-71.
11. Manucci P.M., Bettega D., Cattaneo M. Paterns of development of tachyphylaxis in patients with haemophylia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 1988; 82:87-93.
12. Nicoll D., McPhee S.J., Pigone M., Detmer W.M., Chou T.M. Pocket Guide to Diagnostic Tests, Third Edition Lange/McGraw-Hill 2001 511 p.
13. Nilsson I.M., Mikaelsson M., Vilhardt H. The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons. Scand J Haematol. 1982 Jul;29(1):70-4.
Рецензия
Для цитирования:
Pigarova E.A., Rozhinskaya L.Ya., Chirkova L.D., Il'in A.V. Состояние системы коагуляции у пациентов с центральным несахарным диабетом, получающих десмопрессин, и у пациентов с первичной полидипсией. Ожирение и метаболизм. 2009;6(1):23-28. https://doi.org/10.14341/2071-8713-5105
For citation:
, , , Sostoyanie sistemy koagulyatsii u patsientov s tsentral'nym nesakharnym diabetom, poluchayushchikh desmopressin, i u patsientov s pervichnoy polidipsiey. Obesity and metabolism. 2009;6(1):23-28. https://doi.org/10.14341/2071-8713-5105
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
